CRAMS Industry

  • INR 40000
  • USD 700
Subscribe Now

Annual Review

Piramal

The Indian CRAMS company section in the report provides detailed profiles of key players in the industry which includes their financial and operational data. The player profile also provides the background and other details of the covered company.

Impact Analysis

  • CRAMS growth rate moderates, but prospects remains intact…

    With branded drugs worth ~US$105bn going off-patent by FY20, global pharmaceutical companies are expected to enhance their allocations to R&D to incre.....

    + Know More

Healthcare Coverage

Related Reports

Get Alerts

To receive CARE Research publications and alerts.

Register Now >>